Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
topic_facet:"Recruitment Status: Not yet recruiting"
publishDate:"[2010 TO 2019]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (27)
1
Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer : The Efficacy and Safety of Anlotinib Combined With Nivolumab as a Second-Line Treatment in Patients With Advanced Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
2
The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC : A Randomized Phase II Trial of Brain Radiotherapy Combined With Targeted Therapy in Patients With Asymptomatic NSCLC Brain Metastasis With Gene Sensitive Mutation
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
3
A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer : A Phase II Study of Neoadjuvant Double-drug Chemotherapy With Platinum Plus Anlotinib Hydrochloride in Stage III(N2) Non-small-cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
4
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC : Pembrolizumab + Platinum Doublets Without Radiation for Patients With PD-L1 ≥50% Locally Advanced Non-small Cell Lung Cancer: a Multicenter Prospective Single Arm Phase II Study
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
5
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis : A Randomized Phase II Trial of Osimertinib Alone or in Combination With Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
6
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC : One-arm Exploratory Study on the Efficacy and Safety of Apatinib Combined With SHR-1210 Injection (PD-1 Antibody) in the Treatment of Removable IB-IIIA Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
7
Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) : SUNRISE: A Phase II Randomized Control Study of Sintilimab Combined With Anlotinib Versus Standard Platinum-based Chemotherapy as a First-line Treatment in Patients With Advanced NSCLC
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
8
Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer : A Randomized, Double-Blind, Multicenter, Phase Ⅲ Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
9
Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation : A Phase 2 Study of Pyrotinib in Patients With Non-Small Cell Lung Cancer (NSCLC), With at Least One Prior Systemic Treatment, Locally Advanced or Metastatic, With EGFR or ERBB2 Exon 20 Insertion Mutation (PEER20)
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
10
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI : Safety and Efficacy of Anlotinib Hydrochloride Combined With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in Treating Advanced Non-small-cell Lung Cancer (NSCLC) Patients With Acquired Resistance to EGFR TKIs
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Filter aufheben
Erscheinungsjahr: 2010-2019
Medienart
27
Aufsätze
27
E-Artikel
27
E-Ressourcen
Zeitschriftentitel
27
ClinicalTrials.gov
Thema
27
610
Carcinoma, Non-Small-Cell Lung
Recruitment Status: Not yet recruiting
25
Study Type: Interventional
22
Lung Neoplasms
11
Phase: Phase 2
6
Phase: Phase 3
3
Medical Condition: Non-small Cell Lung Cancer
3
Neoplasm Metastasis
3
Phase: Phase 4
2
Medical Condition: Advanced Non-small Cell Lung...
2
Medical Condition: Non Small Cell Lung Cancer
2
Neoplasms, Second Primary
1
Bone Marrow Diseases
1
Bone Neoplasms
1
Brain Neoplasms
1
Lung Diseases
1
Medical Condition: Advanced Non-squamous Non-sm...
1
Medical Condition: Carcinoma, Non-Small-Cell Lung
1
Medical Condition: Carcinoma, Non-small Cell Lu...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
19
2019
1
2018
4
2017
1
2016
1
2015
1
2013
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
27
Englisch
Haven't found what you're looking for?
Wird geladen...